Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
| Neurocrine Biosciences, Inc. |
| Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, Zydus Healthcare (USA) LLC and Cadila Healthcare Limited |
| 1:2022cv01291 |
| September 30, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 18, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 18
SO ORDERED re (23 in 1:22-cv-00439-MN, 17 in 1:22-cv-01291-MN) Stipulation and Order Regarding Case Consolidation. Signed by Judge Maryellen Noreika on 11/18/2022. (dlw)
|
| Case associated with lead case: Create association to 1:21-cv-01042-MN. (dlw) |
| Filing 17 STIPULATION Regarding Consolidation, Case Schedule, and Protective Order, by Neurocrine Biosciences, Inc.. (Balick, Steven) |
|
SO ORDERED re (16 in 1:22-cv-00965-MN, 22 in 1:22-cv-00439-MN, 11 in 1:22-cv-00639-MN, 74 in 1:21-cv-01042-MN, 11 in 1:22-cv-01061-MN, 16 in 1:22-cv-01291-MN, 10 in 1:22-cv-01124-MN) Stipulated Order - IT IS HEREBY ORDERED that the deadline to advise the Court whether the Non-Consolidated Actions agree to be consolidated and proceed on the Consolidated Action schedule is extended through and including 11/17/2022. ORDERED by Judge Maryellen Noreika on 11/14/2022. (dlw)
|
| Filing 16 STIPULATION Seeking to Extend the Deadline by Which the Parties in the Non-Consolidated Cases Must Inform the Court Whether they Agree to be Consolidated With, and Adopt the Schedule of the Lead Case, by Neurocrine Biosciences, Inc.. (Balick, Steven) |
| Filing 15 REDACTED VERSION of #13 Stipulation of Dismissal by Neurocrine Biosciences, Inc.. (Mayo, Andrew) |
|
Filing 14
[SEALED] SO ORDERED re #13 Stipulation and Order Dismissing Defendant Zydus Healthcare (USA) LLC without Prejudice and Amending Caption to Reflect Same. Party Zydus Healthcare (USA) LLC terminated. Signed by Judge Maryellen Noreika on 11/3/2022. This order has been emailed to local counsel. (dlw)
|
| Filing 13 [SEALED] STIPULATION of Dismissal Without Prejudice (Zydus Healthcare (USA) LLC) and Order Amending Caption by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 11/3/2022 (dlw). |
| Minute Entry for proceedings held before Judge Maryellen Noreika - Telephone Conference held on 11/3/2022. Discussion on the status and schedule of recently-filed cases. The parties in each of the non-consolidated cases shall, within one week, inform the Court if they agree to be consolidated with the Lead Case and proceed on that schedule. (Court Reporter Dale Hawkins.) Associated Cases: 1:21-cv-01042-MN et al.(mdb) |
| Filing 12 WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Lifesciences Limited waiver sent on 10/27/2022, answer due 1/25/2023. (Balick, Steven) |
| Filing 11 WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Worldwide DMCC waiver sent on 10/27/2022, answer due 1/25/2023. (Balick, Steven) |
| Filing 10 WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Healthcare (USA) LLC waiver sent on 10/27/2022, answer due 12/27/2022. (Balick, Steven) |
| Filing 9 WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 10/27/2022, answer due 12/27/2022. (Balick, Steven) |
|
Filing 8
ORAL ORDER RESETTING Teleconference - IT IS HEREBY ORDERED that the 10/24/2022 teleconference is RESET for 11/3/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/19/2022. (dlw)
|
| Filing 7 NOTICE OF SERVICE of Neurocrine Biosciences, Inc.'s First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-41) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) |
|
Filing 6
ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 10/24/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/6/2022. (dlw)
|
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,311,532. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/18/2022. Date of Expiration of Patent: 09/18/2038.Thirty Month Stay Deadline: 10/11/2024. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Zydus Healthcare (USA) LLC, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC ( Filing fee $ 402, receipt number ADEDC-3972643.) - filed by Neurocrine Biosciences, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) |
| No Summons Issued. (mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
